2018
DOI: 10.1136/gutjnl-2017-315136
|View full text |Cite
|
Sign up to set email alerts
|

Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome

Abstract: BackgroundMore effective treatments are needed for patients with postinfectious, diarrhoea-predominant, irritable bowel syndrome (IBS-D). Accordingly, we conducted a randomised, double-blind, placebo-controlled, 8-week-long trial to assess the efficacy and safety of oral glutamine therapy in patients who developed IBS-D with increased intestinal permeability following an enteric infection.MethodsEligible adults were randomised to glutamine (5 g/t.i.d.) or placebo for 8 weeks. The primary end point was a reduct… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
81
0
8

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 136 publications
(95 citation statements)
references
References 33 publications
6
81
0
8
Order By: Relevance
“…54 In a randomized controlled trial, Zhou et al recently showed the beneficial effect of glutamine supplementation on intestinal permeability and gastrointestinal symptoms in post-infectious IBS patients. 56 All these data are in accordance with previous studies showing that glutamine supplementation or deprivation is able to modify TJ protein expression and influence intestinal permeability. 50,57 The mechanisms of action for glutamine remain not completely understood and have been previously discussed.…”
Section: Discussionsupporting
confidence: 92%
“…54 In a randomized controlled trial, Zhou et al recently showed the beneficial effect of glutamine supplementation on intestinal permeability and gastrointestinal symptoms in post-infectious IBS patients. 56 All these data are in accordance with previous studies showing that glutamine supplementation or deprivation is able to modify TJ protein expression and influence intestinal permeability. 50,57 The mechanisms of action for glutamine remain not completely understood and have been previously discussed.…”
Section: Discussionsupporting
confidence: 92%
“…The use of l-Glutamine supplementation to support GI barrier function has received extensive examination [214]. Benefits have repeatedly been shown in humans following large intravenous L -glutamine infusions (~0.2-0.5 g•kg•day −1 ) in patients with critical illness indicative of glutamine deficiency, including severe burns [215,216], post-infectious irritable bowel syndrome [217], and major abdominal trauma [218]. In comparison, benefits are less prominent with low dose oral ingestion (<0.2 g•kg•day −1 ) in chronic GI diseases patients, whom are unlikely to be glutamine deficient and/or exposed to acute stress [219,220].…”
Section: Glutaminementioning
confidence: 99%
“…23 Although digestive health symptoms appear to lack association with IP, this should not undermine the association between gastrointestinal conditions and IP, especially provided the high correlation between the improvement of altered IP and a reduction in postinfectious IBS disease severity purported in the literature. 76 Conversely, many of the risk factors that resemble a metabolic-like condition were found to be associated with IP in the general population. 23,44,56 However, risk factors such as waist-to-hip ratio, waist circumference and elevated triglycerides, were less associated with IP in the general population when compared to a disease state.…”
Section: Strongest Risk Factors For Altered Intestinal Permeabilitymentioning
confidence: 99%